PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
10.42%
Revenue growth at 75-90% of 3391.T's 13.56%. Bill Ackman would push for innovation or market expansion to catch up.
8.17%
Gross profit growth at 50-75% of 3391.T's 10.99%. Martin Whitman would question if cost structure or brand is lagging.
-1.82%
Negative EBIT growth while 3391.T is at 154.87%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
18.93%
Positive operating income growth while 3391.T is negative. John Neff might view this as a competitive edge in operations.
1.60%
Net income growth under 50% of 3391.T's 207.15%. Michael Burry would suspect the firm is falling well behind a key competitor.
1.65%
EPS growth under 50% of 3391.T's 207.16%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
1.65%
Diluted EPS growth under 50% of 3391.T's 206.74%. Michael Burry would worry about an eroding competitive position or excessive dilution.
-0.00%
Share reduction while 3391.T is at 0.00%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.00%
Reduced diluted shares while 3391.T is at 0.04%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
99.82%
Dividend growth under 50% of 3391.T's 21691.70%. Michael Burry might suspect more pressing needs for cash or weaker earnings power.
-52.95%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-67.96%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
15.33%
10Y CAGR of 15.33% while 3391.T is zero. Bruce Berkowitz would see if incremental growth can widen into a significant edge.
15.33%
5Y CAGR of 15.33% while 3391.T is zero. Bruce Berkowitz would see if small improvements can scale into a larger advantage.
15.33%
3Y CAGR of 15.33% while 3391.T is zero. Bruce Berkowitz would see if small gains can accelerate to a more decisive lead.
129.00%
OCF/share CAGR of 129.00% while 3391.T is zero. Bruce Berkowitz might see a slight advantage that could compound over time.
129.00%
OCF/share CAGR of 129.00% while 3391.T is zero. Bruce Berkowitz would see if modest momentum can translate into a bigger competitive lead.
129.00%
3Y OCF/share CAGR of 129.00% while 3391.T is zero. Bruce Berkowitz might see if small gains can expand into a broader advantage.
8.12%
10Y net income/share CAGR of 8.12% while 3391.T is zero. Bruce Berkowitz would see if minor gains can compound into a bigger lead over time.
8.12%
Net income/share CAGR of 8.12% while 3391.T is zero. Bruce Berkowitz would see if small mid-term gains can develop into a bigger lead.
8.12%
3Y net income/share CAGR of 8.12% while 3391.T is zero. Bruce Berkowitz sees if minor improvements can widen to a bigger advantage.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
53.20%
Dividend/share CAGR of 53.20% while 3391.T is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
53.20%
Dividend/share CAGR of 53.20% while 3391.T is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
53.20%
3Y dividend/share CAGR of 53.20% while 3391.T is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
No Data
No Data available this quarter, please select a different quarter.
-4.73%
Inventory is declining while 3391.T stands at 2.23%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
2.98%
Asset growth at 75-90% of 3391.T's 3.75%. Bill Ackman suggests reviewing opportunities to match or surpass the competitor's asset expansion if profitable.
4.13%
BV/share growth above 1.5x 3391.T's 1.49%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-24.33%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.